| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.17 | 0.002 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |